Developing a Drug To Reverse Heart Disease (opens in new tab)

Covered by Fight Aging!

We have spoken with Reason from Repair Biotechnologies about his company’s lead candidate, REP-0004, a drug targeting the liver to reduce excess intracellular free cholesterol. The FDA has […]

Read the original article

Sign in to keep reading the full article.

Sign Up Log In

Covered in 1 article

Fight Aging!·

Covered in 1 article

An Update on Progress at Repair Biotechnologies, Developing Means to Regress Atherosclerotic Plaque